327 filings
Page 4 of 17
SEC STAFF LETTER
a3pm0d 9m6k2a1
6 Sep 23
SEC staff letter
12:00am
ARS
wqoq6ksip mx6
5 Sep 23
Annual report to shareholders
6:17pm
424B3
k4w97lmshakpu455 hy
5 Sep 23
Prospectus supplement
6:02pm
425
hckdsq 2d9cta
1 Sep 23
Business combination disclosure
5:06pm
8-K
trg28714py7dw ba5j0q
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
CORRESP
ktq2sx3zhsr
1 Sep 23
Correspondence with SEC
12:00am
CORRESP
lbbvgjjrqtt s3
23 Aug 23
Correspondence with SEC
12:00am
425
s4whe5m
14 Aug 23
Business combination disclosure
8:06am
8-K
1u68ly
14 Aug 23
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
8:05am
UPLOAD
uvndc4odlw5zo nziw6
9 Aug 23
Letter from SEC
12:00am
SEC STAFF LETTER
jl1hr1
8 Aug 23
SEC staff letter
12:00am
CORRESP
7f2goj5u 47
26 Jul 23
Correspondence with SEC
12:00am
UPLOAD
230nillo0smm189kb
19 Jul 23
Letter from SEC
12:00am
S-4/A
1p8l9g sf
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
CORRESP
r67dqzoj9 02p
30 Jun 23
Correspondence with SEC
12:00am